Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey Smith

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
CNS Drugs|January 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic ApproachVivien Li, Fiona C McKay, David C Tscharke, et al.
Iscience|November 11, 2024
High glycemic variability is associated with a reduced T cell cytokine response to influenza A virusMarcus Z W Tong, Katina D Hulme, Soi Cheng Law, et al.
Nature|November 27, 2021
Multiview confocal super-resolution microscopyYicong Wu, Xiaofei Han, Yijun Su, et al.
Immunology and Cell Biology|March 25, 2015
Naive CD8⁺ T-cell precursors display structured TCR repertoires and composite antigen-driven selection dynamicsMichelle A Neller, Kristin Ladell, James E McLaren, et al.
Nature Communications|June 27, 2023
In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprintingWen Juan Tu, Michelle Melino, Jenny Dunn, et al.
Immunity|May 4, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronavirusesKatie E Lineburg, Emma J Grant, Srividhya Swaminathan, et al.
BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.
Cancer Discovery|November 9, 2019
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor ImmunityXian-Yang Li, Achim K Moesta, Christos Xiao, et al.
Research Square|January 9, 2026
An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte ActivationJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.
The Journal of Clinical Investigation|April 1, 2024
IL-6-mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantationPing Zhang, Peter Fleming, Christopher E Andoniou, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
CNS Drugs|January 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic ApproachVivien Li, Fiona C McKay, David C Tscharke, et al.
Iscience|November 11, 2024
High glycemic variability is associated with a reduced T cell cytokine response to influenza A virusMarcus Z W Tong, Katina D Hulme, Soi Cheng Law, et al.
Nature|November 27, 2021
Multiview confocal super-resolution microscopyYicong Wu, Xiaofei Han, Yijun Su, et al.
Immunology and Cell Biology|March 25, 2015
Naive CD8⁺ T-cell precursors display structured TCR repertoires and composite antigen-driven selection dynamicsMichelle A Neller, Kristin Ladell, James E McLaren, et al.
Nature Communications|June 27, 2023
In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprintingWen Juan Tu, Michelle Melino, Jenny Dunn, et al.
Immunity|May 4, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronavirusesKatie E Lineburg, Emma J Grant, Srividhya Swaminathan, et al.
BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.
Cancer Discovery|November 9, 2019
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor ImmunityXian-Yang Li, Achim K Moesta, Christos Xiao, et al.
Research Square|January 9, 2026
An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte ActivationJill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou, et al.
The Journal of Clinical Investigation|April 1, 2024
IL-6-mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantationPing Zhang, Peter Fleming, Christopher E Andoniou, et al.
Pageof 17